Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7121 - 7128 of 12089 results
Is “Class Arbitration” an Oxymoron? (2) Examining Theoretical Bases for Class Arbitration
April 25, 2017| Blog| Viewpoint
Supreme Court Confirms Deferential Standard of Review for EEOC Subpoenas
April 25, 2017| Blog| Viewpoint
Federal Circuit to PTAB: No Short Cuts Allowed
April 25, 2017| Blog| Viewpoint
California Advances PBM Licensing and “Transparency” Law
April 25, 2017| Blog| Viewpoint
Second Circuit Panel: No, We Still Can’t Overturn Precedent on Sexual Orientation Discrimination
April 24, 2017| Blog| Viewpoint
A Spring Cheat Sheet to Congressional Health Care Policy
April 24, 2017| Blog| Viewpoint
Health Care Weekly Preview from ML Strategies - Week of April 24, 2017
April 24, 2017| Blog| Viewpoint
For closely held companies: Is there, or will there soon be, a significant lender in your life?
April 24, 2017| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|